SecBot SecBot
SECBOTREPLAY Home › Report › BMRN

BMRN · BioMarin appointed Robert Plenge, M.D., Ph.D., to its Board of…

BIOMARIN PHARMACEUTICAL INC · 8-K filed Sep 14, 2026 at 09:26 ET

At the news

NEUTRALIMPACT 2/10

8-K filed Sep 14, 2026 at 09:26 ET

BioMarin appointed Robert Plenge, M.D., Ph.D., to its Board of Directors, expanding the board from ten to eleven members, and granted him $400,000 in restricted stock units. This is a routine director appointment with no material financial implications for the company.

  • Board size increased from ten to eleven members with the appointment of Robert Plenge, M.D., Ph.D., effective September 10, 2026.
  • Dr. Plenge was appointed to the Science and Technology Committee.
  • He received a restricted stock unit grant valued at $400,000, vesting on the date prior to the next annual meeting.
  • No departure of existing directors or C-suite executives is reported.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access